U

Novo Integrated Sciences, Inc. NVOS

$0.00 $0.0016.67% OTC PK
Recommendation
Dividend Power Score
Day's Range
$0.00$0.00
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

NVOS Rating

Reward
Risk

NVOS Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

NVOS Company Overview

Novo Integrated Sciences, Inc. is a publicly traded healthcare services and technology company focused on integrated healthcare delivery, medical rehabilitation, clinical wellness services, and healthcare-related technology solutions. The company operates primarily in the healthcare and wellness industries, with activities spanning multidisciplinary clinics, rehabilitation programs, elder care support, healthcare technology commercialization, and medical services management. Novo Integrated Sciences has also pursued initiatives tied to healthcare fintech and asset-backed financial platforms through strategic partnerships and licensing arrangements.

The company’s primary revenue drivers historically have included patient care services, rehabilitation treatments, clinical assessments, and healthcare program management delivered through affiliated clinics and healthcare practitioners. Novo has positioned itself around an integrated care model that combines physical rehabilitation, chronic care management, and technology-enabled healthcare coordination. Public filings indicate the company evolved through acquisitions and healthcare network expansion, particularly in Canada, while also pursuing international financing and infrastructure-related healthcare opportunities. The company has periodically announced strategic initiatives involving medical technology commercialization and structured finance transactions, though some initiatives remain developmental or subject to regulatory and financing conditions based on available public disclosures.

Data compiled by narrative technology. May contain errors.
Sector

NVOS Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

NVOS Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

NVOS Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

NVOS Price History

Loading...
52-Week Range2% of range
Current
$0.00
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

NVOS Valuation

Market Cap
Market Cap Rank
#19,875
Enterprise Value
--
Price/Sales (TTM)
Price/Book (Q)

NVOS Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

NVOS Corporate Info

Phone Number
206 617 9797
Address
11120 NE 2nd Street
Suite 100
Bellevue, WA 98004
Country
Year Founded
--

NVOS Filings

Filing Date
Wednesday, December 18, 2024
Period Date
Monday, September 30, 2024
Next Filing
(est)

NVOS Headlines

There are no news to display.